Directory
>
Paul Rejto
Paul Rejto
Vice President, Discovery Technologies
San Diego, California, United States
Paul Rejto
Summary
Paul Rejto is a seasoned Vice President at Pfizer, specializing in Discovery Technologies with a strong focus on cancer research and biomarker discovery. With over 25 years of experience in the pharmaceutical industry, he has successfully led teams in translational medicine and computational biology, driving innovative solutions to complex challenges in drug discovery. His academic background includes a Ph.D. from Stanford and post-doctoral research at UC Berkeley, providing him with a solid foundation in chemistry and physics. Paul is not only a technical leader but also a strategic thinker, actively involved in the Oncology R&D Board at Pfizer. He is passionate about delivering breakthrough cancer therapies that address unmet medical needs, showcasing a commitment to advancing healthcare. His interests extend beyond the lab, as he is also an avid chess player, reflecting his analytical mindset and strategic thinking abilities.
Paul Rejto
Work Experience
Vice President, Discovery Technologies at
Pfizer, Inc.
April 2020 - Present
Paul Rejto
Education
Stanford University, Ph.D.
January 1970 - January 1970
Harvard University, A.B.
January 1970 - January 1970
University of California, Berkeley, Post-Doctoral Fellow
January 1970 - January 1970
Frequently Asked Questions about Paul Rejto
What is Paul Rejto email address?
Paul Rejto's primary email address is **********@pfizer.com. To view the full verified email and additional contact details, sign up for free with Muraena.
Where Paul Rejto graduated from?
Paul Rejto holds a degree in from Stanford University.
How can I directly contact Paul Rejto?
To contact Paul Rejto directly, you can use the email address **********@pfizer.com. Complete contact information is available upon registration with Muraena.
Who is Paul Rejto?
Paul Rejto is a seasoned Vice President at Pfizer, specializing in Discovery Technologies with a strong focus on cancer research and biomarker discovery. With over 25 years of experience in the pharmaceutical industry, he has successfully led teams in translational medicine and computational biology, driving innovative solutions to complex challenges in drug discovery. His academic background includes a Ph.D. from Stanford and post-doctoral research at UC Berkeley, providing him with a solid foundation in chemistry and physics. Paul is not only a technical leader but also a strategic thinker, actively involved in the Oncology R&D Board at Pfizer. He is passionate about delivering breakthrough cancer therapies that address unmet medical needs, showcasing a commitment to advancing healthcare. His interests extend beyond the lab, as he is also an avid chess player, reflecting his analytical mindset and strategic thinking abilities.
Paul`s contact details
**********@pfizer.com